Usability of mepolizumab single-use prefilled syringe for patient self-administration-Reference-Cited by-同舟云学术

Usability of mepolizumab single-use prefilled syringe for patient self-administration

Published:2019-04-24 Issue:7 Volume:57 Page:755-764
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Bel Elisabeth H.¹,I. Bernstein David²,Bjermer Leif³,Follows Richard⁴,Bentley Jane H.⁵,Pouliquen Isabelle⁶,Bradford Eric⁷

Affiliation:

1. Department of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands;

2. Division of Immunology, Allergy and Rheumatology, University of Cincinnati College of Medicine, Cincinnati, OH, USA;

3. Department of Respiratory Medicine & Allergology, Skåne University Hospital, Lund, Sweden;

4. Respiratory Therapeutic Area, GSK, Uxbridge, UK;

5. Clinical Statistics, GSK, Uxbridge, UK;

6. Clinical Pharmacology Modelling & Simulation, GSK, Uxbridge, UK;

7. Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA

Funder

GlaxoSmithKline

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology, and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2019.1604745

Reference16 articles.

1. GSK. Nucala. US Prescribing information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125526s004lbl.pdf [last accessed October 2018].

2. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

3. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

4. Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

5. Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-administration of biologicals for severe asthma: insights for clinicians;Minerva Respiratory Medicine;2024-03

2. Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab;Pediatric Drugs;2023-09-02

3. Biological therapy management from the initial selection of biologics to switching between biologics in severe asthma;Tuberk Toraks;2023-03-10

4. A Review of Adverse Reactions to Biologics Used in Allergy-Immunology Practice;The Journal of Allergy and Clinical Immunology: In Practice;2022-12

5. Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases;Current Allergy and Asthma Reports;2022-10-28